SCHEMBL6607413

SCHEMBL6607413

CSc1ccc(N2C[C@H](COc3ccccn3)OC2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607279 0.84 GRM2 (0.53) GRM2
SCHEMBL7082493 0.83 GRM2 (0.48) GRM2
SCHEMBL7082491 0.83 GRM2 (0.48) GRM2
SCHEMBL11069385 0.80 GRM2 (0.52) GRM2
SCHEMBL7164286 0.80 GRM2 (0.47) GRM2
SCHEMBL7164281 0.80 GRM2 (0.47) GRM2
SCHEMBL5235122 0.76 GRM2 (0.47) GRM2
SCHEMBL6211849 0.76 GRM2 (0.46) GRM2
SCHEMBL6211853 0.76 GRM2 (0.46) GRM2
SCHEMBL2411700 0.76 HDAC1 (0.48) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082322-B1 OXAZOLIDINONE DERIVATIVES AS ANTIBIOTIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 2004-01-28 EP disclosed
EP-1357122-A2 Oxazolidinone compounds and pharmaceutical compositions containing them AstraZeneca AB (SE) 2003-10-29 EP disclosed